GNC balances science, consumer demand and rising costs in supplement innovation

For GNC, successful supplement innovation starts with understanding what consumers want—but turning those insights into market-ready products requires balancing scientific evidence, formulation feasibility and affordability.

Speaking with NutraIngredients at SupplySide Global, Rachel Jones, EVP, Chief Merchandising and Science Office, GNC, said the retailer draws on consumer research, in-store interactions and online search behavior to identify emerging needs before assessing whether the market has the ingredients, technology and clinical evidence to deliver.

“Fortunately, with our stores and our website, we can really tap into what consumers are searching for,” Jones said, adding that events like SupplySide Global help determine whether an idea can realistically be brought to life.

One of the biggest challenges is balancing ambitious formulations with consumer price expectations. Jones said her team of scientists often develop premium formulas, only to find that the combined cost of ingredients and technologies make the finished products prohibitively expensive.

“It’s really being very focused on the most important benefits and features and making sure that you can get them in there with a cost framework that will work for the consumer,” she said.

Rising ingredient and manufacturing costs have also prompted GNC to rethink its approach through what CEO Michael Costello calls “cost-ovation” – identifying expenses consumers don’t necessarily value so the company can protect investment in science and quality.

That has meant reassessing packaging materials and colors, as well as promotional strategies, rather than compromising on ingredients or formulation quality.

Jones said branded ingredients can also help communicate product differentiation, particularly when supported by clinical evidence. However, she cautioned that brands must be selective, as not every trademarked ingredient has the same level of substantiation.

Explore related questions

Looking ahead, Jones said GNC is particularly interested in clinically supported ingredients that deliver noticeable consumer experiences and can be incorporated into convenient formats like powders, liquids, chewables and direct-to-mouth products.